Clomilad Driada Medical

£37.00

Clomilad Driada Medical contains clomiphene citrate, a selective estrogen receptor modulator extensively studied in research protocols for post-cycle therapy applications and hormonal modulation investigations.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Clomilad Driada Medical
Clomilad Driada Medical
£37.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Clomilad Driada Medical — Research Summary

Clomilad Driada Medical is a selective estrogen receptor modulator containing clomiphene citrate as its active pharmaceutical component. This compound demonstrates dual-mechanism activity, functioning as both an estrogen receptor antagonist and partial agonist depending on tissue-specific receptor expression. Research applications focus on its ability to modulate hypothalamic-pituitary-gonadal axis function through competitive binding at estrogen receptor sites. Scientists at Stroid UK Shop examine this SERM for its established role in endocrine research protocols, particularly those investigating hormonal recovery mechanisms following experimental interventions.

Laboratory Applications

Research protocols utilise clomiphene citrate to investigate gonadotropin release patterns and testosterone recovery mechanisms in controlled laboratory environments. Studies examine its capacity to stimulate luteinising hormone and follicle-stimulating hormone secretion through hypothalamic estrogen receptor blockade. Investigators analyse its pharmacokinetic properties, including hepatic metabolism via CYP2D6 and CYP3A4 pathways. Laboratory models evaluate tissue-selective effects, comparing agonist activity in bone tissue against antagonist properties in breast tissue. Research within post cycle therapy frameworks examines recovery timelines and hormonal restoration patterns. Comparative studies alongside SARMs and peptides provide researchers with comprehensive data on endocrine modulation approaches.

Technical Specifications

Clomilad Driada Medical Research Parameters
Parameter Specification
Active Compound Clomiphene Citrate
CAS Number 50-41-9
Molecular Formula C₃₂H₃₆ClNO₈
Molecular Weight 598.08 g/mol
Presentation Oral tablets
Purity Verify with supplier
Storage Conditions Room temperature, dry environment
Research Classification SERM (Selective Estrogen Receptor Modulator)

Compliance Statement

Clomilad Driada Medical is supplied exclusively for in-vitro research purposes and laboratory investigations. This product is not intended for human consumption, clinical application, or therapeutic use. Researchers must ensure appropriate institutional oversight and safety protocols when handling this compound. All investigations should comply with relevant research guidelines and institutional review board requirements. Purchase and use of this product confirms understanding of its research-only designation and acceptance of appropriate handling responsibilities within professional laboratory environments.

Related